|Videos|July 8, 2020

Long-Term PrEP Continuum of Care Patterns

Uncovering interesting findings regarding patients' PrEP regimen.

In an interview with Contagion during International AIDS Society (IAS) AIDS 2020 Virtual Sessions this week, Jonathan Volk, MD, MPH, infectious disease clinician, Kaiser Permanente San Francisco Medical Center spoke about his study, the PrEP Continuum of Care and New HIV infections: Long-Term Follow-Up in a Large Clinical Cohort.

Volk spoke of the study’s findings including the fact many patients do not complete key steps in PrEP continuum of care, resulting in preventable HIV infections.

There were several other discoveries from the observational data. For one, patients had the greatest drop off from taking their PrEP regimen in the first year of care. He said there was a 27% drop off. After that first year, a large majority of patients stayed on their regimen.

They have tools in place to survey their patients to see if PrEP is something they want to continue.

In looking at the African American population, this patient group was less likely to get a prescription, less likely to initiate PrEP, and more likely to discontinue PrEP.

In addition, he talked about looking at identifying patient populations earlier in their care who might be able to benefit from PrEP care.

Volk also spoke of the influence of COVID-19 including how they are working with patients remotely.


Related to this article

How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.